GLRB Chromosome 4
Glycine receptor beta
Upload your DNA to see your personal genotypes for variants in GLRB.
What This Gene Does
This gene encodes the beta subunit of the glycine receptor, which is a pentamer composed of alpha and beta subunits. The receptor functions as a neurotransmitter-gated ion channel, which produces hyperpolarization via increased chloride conductance due to the binding of glycine to the receptor. Mutations in this gene cause startle disease, also known as hereditary hyperekplexia or congenital stiff-person syndrome, a disease characterized by muscular rigidity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Gene Info
Gene Group
Glycine receptors
Locus Type
gene with protein product
Location
4q32.1
Ensembl
ENSG00000109738
Associated Conditions (5)
Hyperekplexia 2
Inborn genetic diseases
GLRB-related disorder
Seizure
Gastric cancer
Key Variants
RS1440659826
Conflicting classifications of pathogenicity
Hyperekplexia 2, Hyperekplexia 2
Health Risk
RS144279427
Conflicting classifications of pathogenicity
Hyperekplexia 2, Inborn genetic diseases, Hyperekplexia 2
Health Risk
RS147320218
Conflicting classifications of pathogenicity
Hyperekplexia 2, Hyperekplexia 2
Health Risk
RS149863285
Conflicting classifications of pathogenicity
Hyperekplexia 2, Hyperekplexia 2
Health Risk
RS199840817
Conflicting classifications of pathogenicity
Hyperekplexia 2, GLRB-related disorder, Inborn genetic diseases
Health Risk
RS377603371
Conflicting classifications of pathogenicity
Hyperekplexia 2, Inborn genetic diseases, Hyperekplexia 2
Health Risk
RS555010961
Conflicting classifications of pathogenicity
Hyperekplexia 2, Inborn genetic diseases, Hyperekplexia 2
Health Risk
RS570886685
Conflicting classifications of pathogenicity
Inborn genetic diseases, Hyperekplexia 2, Inborn genetic diseases
Health Risk
RS745824514
Conflicting classifications of pathogenicity
Hyperekplexia 2, Inborn genetic diseases, Hyperekplexia 2
Health Risk
RS750803516
Conflicting classifications of pathogenicity
Hyperekplexia 2, Hyperekplexia 2
Health Risk
RS2530082710
Likely pathogenic
Seizure, Seizure
Health Risk
RS771465893
Likely pathogenic
Hyperekplexia 2, Gastric cancer, Hyperekplexia 2
Health Risk
All Variants (27)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS1440659826 | Health Risk | Conflicting classifications of pathogenicity | Hyperekplexia 2, Hyperekplexia 2 |
| RS144279427 | Health Risk | Conflicting classifications of pathogenicity | Hyperekplexia 2, Inborn genetic diseases, Hyperekplexia 2 |
| RS147320218 | Health Risk | Conflicting classifications of pathogenicity | Hyperekplexia 2, Hyperekplexia 2 |
| RS149863285 | Health Risk | Conflicting classifications of pathogenicity | Hyperekplexia 2, Hyperekplexia 2 |
| RS199840817 | Health Risk | Conflicting classifications of pathogenicity | Hyperekplexia 2, GLRB-related disorder, Inborn genetic diseases |
| RS377603371 | Health Risk | Conflicting classifications of pathogenicity | Hyperekplexia 2, Inborn genetic diseases, Hyperekplexia 2 |
| RS555010961 | Health Risk | Conflicting classifications of pathogenicity | Hyperekplexia 2, Inborn genetic diseases, Hyperekplexia 2 |
| RS570886685 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Hyperekplexia 2, Inborn genetic diseases |
| RS745824514 | Health Risk | Conflicting classifications of pathogenicity | Hyperekplexia 2, Inborn genetic diseases, Hyperekplexia 2 |
| RS750803516 | Health Risk | Conflicting classifications of pathogenicity | Hyperekplexia 2, Hyperekplexia 2 |
| RS2530082710 | Health Risk | Likely pathogenic | Seizure, Seizure |
| RS771465893 | Health Risk | Likely pathogenic | Hyperekplexia 2, Gastric cancer, Hyperekplexia 2 |
| RS121909749 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS1380139789 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS1415892964 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS1560962569 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS1560962636 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS1579175843 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS2126566107 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS2530068462 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS2530068914 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS2531235100 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS373790643 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS746631259 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS768063841 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS770934436 | Health Risk | Pathogenic | Hyperekplexia 2, Hyperekplexia 2 |
| RS281864922 | Health Risk | Pathogenic/Likely pathogenic | Hyperekplexia 2, Hyperekplexia 2 |